Table 2.
RAND-36 subdomain scores in patients (Men, Women, and Total) with PAI compared with normative data.
PF | RP | BP | GH | VT | SF | RE | MH | |
---|---|---|---|---|---|---|---|---|
Total | ||||||||
PAI | 90 | 75 | 74 | 57 | 50 | 88 | 100 | 80 |
Median [IQR] | [72-95] | [0-100] | [51-100] | [35-77] | [30-65] | [62-100] | [67-100] | [68-88] |
Normative | 95 | 100 | 84 | 65 | 60 | 100 | 100 | 84 |
Median [IQR] | [85-100] | [50-100] | [51-100] | [50-75] | [45-75] | [75-100] | [100-100] | [72-92] |
p-value | <0.001* | <0.001* | 0.566 | <0.001* | <0.001* | <0.001* | <0.001* | 0.001* |
Men | ||||||||
PAI | 95 | 100 | 84 | 62 | 60 | 88 | 100 | 84 |
Median [IQR] | [85-100] | [25-100] | [61-100] | [40-82] | [40-70] | [75-100] | [84-100] | [72-92] |
Normative | 95 | 100 | 84 | 67 | 65 | 100 | 100 | 84 |
Median [IQR] | [85-100] | [75-100] | [52-100] | [55-77] | [50-80] | [75-100] | [100-100] | [72-92] |
p-value | 0.060 | <0.001* | 0.193 | 0.071 | <0.001* | 0.001* | 0.209 | 0.270 |
Women | ||||||||
PAI | 85 | 50 | 72 | 55 | 45 | 75 | 100 | 80 |
Median [IQR] | [65-95] | [0-100] | [51-100] | [30-77] | [30-60] | [62-100] | [33-100] | [67-88] |
Normative | 95 | 100 | 74 | 65 | 60 | 100 | 100 | 84 |
Median [IQR] | [80-100] | [50-100] | [51-100] | [50-75] | [45-70] | [75-100] | [67-100] | [72-92] |
p-value | <0.001* | <0.001* | 0.208 | <0.001* | <0.001* | <0.001* | <0.001* | 0.002* |
PAI, primary adrenal insufficiency; IQR, interquartile range; PF, physical functioning; RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health. *; statistically significant defined as p < 0.010.